Catechol-Benzothiazole Conjugates: Antibacterial Synergists Against Pseudomonas aeruginosa

236.5 KB of molecular structure data from a study identifying a hit compound, 4p, with an IC50 of 0.27 μM for biofilm inhibition. The dataset, authored by Ying-Bo Zhou and last updated in May 2026, contains results from in vitro and in vivo experiments demonstrating synergy with antibiotics. It likely includes structural data for a series of synthesized catechol-conjugated benzothiazole derivatives.

Use Cases

• Training models to predict biofilm inhibition based on molecular structure features mentioned in the description
• Analyzing structure-activity relationships for catechol-conjugated benzothiazole derivatives
• Studying the synergy between novel compounds and existing antibiotics like ciprofloxacin and tobramycin

Strengths

• Includes a hit compound with a specific, potent biofilm inhibition value (IC50 = 0.27 μM)
• Contains in vivo validation data showing a 2.10–2.11 log10 CFU reduction in mouse wound models

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The 236.5 KB size indicates a very limited scope of data

Provenance

Source

figshare

Collection Method

Data likely originates from laboratory synthesis and biological testing described in the associated research.

Freshness

Last updated 2026-05-04 10:13:30; freshness should be verified